Meeting
2017 Gastrointestinal Cancers Symposium
A single institutional experience of carbon-ion radiotherapy for locally advanced pancreatic cancer.
Authors
Makoto Shinoto
Ion Beam Therapy Center, SAGA HIMAT Foundation, Tosu, Japan
Makoto Shinoto , Yoshiyuki Shioyama , Hiroaki Suefuji , Shingo Toyama , Keiji Matsumoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 461)
DOI
10.1200/JCO.2017.35.4_suppl.461
Abstract #
461
Poster Bd #
M1
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Long-term outcome after combined carbon-ion radiotherapy and chemotherapy for locally advanced pancreatic cancer.
First Author: Makoto Shinoto
Poster
2016 Gastrointestinal Cancers Symposium
Local effect and gastrointestinal toxicity for carbon-ion radiotherapy in patients with unresectable locally advanced pancreatic cancer.
First Author: Makoto Shinoto
Poster
2022 ASCO Annual Meeting
Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial.
First Author: Fabienne Portales
Poster
2022 ASCO Annual Meeting
Do we need postoperative chemotherapy after preoperative FOLFIRINOX in resected borderline or locally advanced pancreatic cancer? A retrospective analysis.
First Author: Roxane Mari